This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
30 Jul 2014

Registration Opens for the Respiratory Drug Delivery Asia 2014 Scientific Conference

The Respiratory Drug Delivery (RDD) Asia 2014 scientific conference will welcome pulmonary and nasal drug delivery experts from all over the world to Goa, India from 12–14 November 2014. The joint organisers of the first edition of RDD Asia — Aptar Pharma and RDD Online announce the opening of registration.



Bringing the Respiratory World Together for the First Time in Asia

RDD scientific conferences are globally regarded as the premier venue for presenting the latest advances in
pulmonary and nasal drug delivery. They take place in Europe (RDD Europe) and the US (RDD US) in alternate years.


After a successful RDD US 2014 held last month in Fajardo, Puerto Rico, the respiratory world is looking forward to the first RDD Asia meeting, which showcases one of the world’s most prominent emerging markets and a growing location for inhaler and nasal spray development.


RDD Asia 2014 seeks to link Asian regulators, industrial and academic scientists, clinicians and business
professionals with their international counterparts, together working toward the goal of advancing inhaled and
nasal drug therapy worldwide.


RDD Asia, like its predecessors in the US and Europe, will feature lively, fresh and focused updates on respiratory drug delivery in Asia and the rest of the world.


More than 200 delegates from Asia and beyond are expected to attend the conference which will be held at the Goa Marriott Resort & Spa in India. The meeting is jointly managed by RDD Online and Apta Pharma.

A 2-day scientific symposium of the highest level in India

The RDD Asia 2014 scientific conference will feature podium sessions, scientific poster sessions, a technology exhibition and workshop sessions focused on
- Global Regulation of Inhaled and Nasal Drug Products
- New Therapeutic Opportunities
- Generic Product Development
- Advanced Drug Delivery Technologies
- Current Issues in Inhaled and Nasal Drug Product Testing.

 

Expert speakers will address a blend of contemporary issues and essential background relating to pMDIs, DPIs, nebulizers, nasal sprays and emerging aerosol delivery platforms.


RDD Asia 2014 will also offer several networking opportunities, including a cocktail reception on 12 November and a gala dinner on 13 November sponsored by Aptar Pharma.

Related News